Information  X 
Enter a valid email address

Seed Innovations Ltd (SEED)

  Print   

Monday 29 November, 2021

Seed Innovations Ltd

Change of Registered Address and of Administrator

RNS Number : 9328T
Seed Innovations Limited
29 November 2021
 

Seed Innovations Limited / AIM: SEED / Sector: Closed End Investments

29 November 2021

 

SEED Innovations Limited ("SEED" or the "Company")

 Change of Registered Address and Change of Administrator

SEED Innovations Limited, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health, and wellness space, announces effective immediately a change in Administrator and Secretary to Obsidian Fund Services Limited. Following this change the registered office of the Company is now PO Box 343, Obsidian House, La Rue D'Aval, Vale, Guernsey GY6 8LB.

 

*** ENDS***

 

 For further information on the Company please visit  www.seedinnovations.co  or contact:

 

Ed McDermott /

Lance de Jersey

SEED Innovations Ltd

Email:   [email protected]

 

James Biddle /

Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

Isabella Pierre /

Damon Heath

Shard Capital Partners LLP

 

T: +44 (0)20 7186 9927

Catherine Leftley /

Isabel de Salis

St Brides Partners Ltd,

Financial PR

 

Email: [email protected]

 

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CROEAKFNAFPFFFA

a d v e r t i s e m e n t